Study to assess the safety of 3 differing concentrations of BMP-655/ACS in subjects with full thickness Rotator Cuff Tears (RCTs).
This decision to terminate enrollment in this study is based on the company's change in prioritization for the portfolio and was not due to any safety concerns, or regulatory interactions. Patients already enrolled in the study, should continue to complete assessments as described in the protocol.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
13
Decision was made by Legal to withhold this information
Decision was made by Legal to withhold this information.
Decision was made by Legal to withhold this information,
Pfizer Investigational Site
Berlin, Germany
Pfizer Investigational Site
Hamburg, Germany
Pfizer Investigational Site
Amsterdam, Netherlands
Pfizer Investigational Site
Hoofddorp, Netherlands
Abnormal X-rays, MRIs, CT scans, physical examination of limb, functional evaluations, AE/SAE, vital signs, subject assessment of pain, lab tests
Time frame: 1 year
Investigator Questionnaire
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.